Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Jessen

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Plos One|November 12, 2015
High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in GermanyKlaus Jansen, Michael Thamm, Claus-Thomas Bock, et al.
AIDS (London, England)|December 31, 2008
A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progressionDjin-Ye Oh, Konstantin Baumann, Osamah Hamouda, et al.
Communications Medicine|December 2, 2025
Ultra-low level HIV p24 drives immune activation in antiretroviral therapy-treated people living with HIVEnrico Richter, Julia König, Antonia Büning, et al.
AIDS Patient Care and Stds|November 20, 2025
Inconsistent Condom Use and Reasons for Non-Use in the Era of HIV Pre-Exposure Prophylaxis Among German Men Who Have Sex with MenSarah Moreland, Kartavya J Vyas, Heiko Jessen, et al.
AIDS (London, England)|December 23, 2008
Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcomeHendrik Streeck, Heiko Jessen, Claudia Kuecherer, et al.
Plos One|September 14, 2018
Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin - A multicentre, cross-sectional surveyRicardo Niklas Werner, Matthew Gaskins, Jens Ahrens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2014
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trialAlan Winston, Janaki Amin, Amanda Clarke, et al.
Journal of Virology|February 27, 2015
Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllersTadashi Kikuchi, Yukie Iwabu, Takuya Tada, et al.
The Lancet. Infectious Diseases|April 17, 2015
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study, Dianne Carey, Rebekah Puls, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 18, 2020
Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventionsRuth Zimmermann, Mirko Faber, Sandra Dudareva, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Plos One|November 12, 2015
High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in GermanyKlaus Jansen, Michael Thamm, Claus-Thomas Bock, et al.
AIDS (London, England)|December 31, 2008
A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progressionDjin-Ye Oh, Konstantin Baumann, Osamah Hamouda, et al.
Communications Medicine|December 2, 2025
Ultra-low level HIV p24 drives immune activation in antiretroviral therapy-treated people living with HIVEnrico Richter, Julia König, Antonia Büning, et al.
AIDS Patient Care and Stds|November 20, 2025
Inconsistent Condom Use and Reasons for Non-Use in the Era of HIV Pre-Exposure Prophylaxis Among German Men Who Have Sex with MenSarah Moreland, Kartavya J Vyas, Heiko Jessen, et al.
AIDS (London, England)|December 23, 2008
Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcomeHendrik Streeck, Heiko Jessen, Claudia Kuecherer, et al.
Plos One|September 14, 2018
Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin - A multicentre, cross-sectional surveyRicardo Niklas Werner, Matthew Gaskins, Jens Ahrens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2014
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trialAlan Winston, Janaki Amin, Amanda Clarke, et al.
Journal of Virology|February 27, 2015
Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllersTadashi Kikuchi, Yukie Iwabu, Takuya Tada, et al.
The Lancet. Infectious Diseases|April 17, 2015
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study, Dianne Carey, Rebekah Puls, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 18, 2020
Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventionsRuth Zimmermann, Mirko Faber, Sandra Dudareva, et al.
Pageof 8